Genetic Signatures Revenue and Competitors

Newtown, Australia

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Genetic Signatures's estimated annual revenue is currently $17.1M per year.(i)
  • Genetic Signatures's estimated revenue per employee is $155,000

Employee Data

  • Genetic Signatures has 110 Employees.(i)
  • Genetic Signatures grew their employee count by -1% last year.

Genetic Signatures's People

NameTitleEmail/Phone
1
Chief Financial and Operating Officer, and Company SecretaryReveal Email/Phone
2
Purchasing OfficerReveal Email/Phone
3
Regulatory Affairs ManagerReveal Email/Phone
4
Technical Support ManagerReveal Email/Phone
5
Quality Control ManagerReveal Email/Phone
6
Senior Field Application ScientistReveal Email/Phone
7
UK Regional Sales ManagerReveal Email/Phone
8
Regulatory Affairs AssociateReveal Email/Phone
9
SalesReveal Email/Phone
10
AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.4M33828%N/AN/A
#2
$13.8M899%N/AN/A
#3
$18.6M12021%N/AN/A
#4
$17.1M110-1%N/AN/A
#5
$48.1M3106%N/AN/A
#6
$15.3M9927%N/AN/A
#7
$13.6M88-14%N/AN/A
#8
$15.5M1009%N/AN/A
#9
$19.7M1278%N/AN/A
#10
$21.2M137-4%$33.8MN/A
Add Company

What Is Genetic Signatures?

Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3base. Our EasyScreen products simultaneously detect a larger number of infectious pathogen targets in a shorter time than conventional methods. Our single universal sample preparation method is suitable for bacterial, protozoan or viral (DNA & RNA) targets and is automatable via the GS1 automation platform or the most common commercial extraction platforms. Our assays are also compatible with all major real-time PCR instruments. Moreover, each product comes complete with extraction and internal controls to ensure sample integrity, correct sample processing, and PCR inhibition.

keywords:N/A

N/A

Total Funding

110

Number of Employees

$17.1M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genetic Signatures News

2022-04-20 - In Brief This Week: Natera, Caris Life Sciences, Fulgent ...

Fulgent Genetics said this week that it has completed the ... Genetic Signatures this week reported A$8.7 million (US$6.2 million) in sales...

2022-04-17 - Largest Genetic Study to Date Unveils DNA Profiles That Lead ...

Eventually, with no regard for their neighbors, mutated cells destroy tissues, organs, and life. But their set of genetic mutations—a signature—...

2022-04-13 - Long-term artificial selection of Hanwoo (Korean) cattle left ...

Long-term artificial selection of Hanwoo (Korean) cattle left genetic signatures for the breeding traits and has altered the genomic...

2019-09-08 - Genetic Signatures Limited (ASX:GSS), Walker Greenbank ...

Genetic Signatures Limited (ASX:GSS) has a Price to Book ratio of 9.895330. This ratio is calculated by dividing the current share price by the ...

2019-09-07 - Science hasn't found a 'gay gene' — so what?

He said he got warned that if he found any distinct genetic signatures, someone would abuse them for the purposes of discrimination, or worse.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.4M1225%N/A
#2
$13M127-51%N/A
#3
$37.7M1307%N/A
#4
$35.9M1334%N/A
#5
$19.3M1333%N/A